COMMUNIQUÉS West-GlobeNewswire
-
VALNEVA : Déclaration d’actions et de droits de vote - Statut au 31 mai 2026
03/06/2026 -
Curiox Automates Flow Cytometry Sample Prep End-to-End on a Single Instrument
03/06/2026 -
Medical Grade Physiotherapy & Wellness Now Accepting New Clients in Burlington, Ontario — Redefining One-on-One Rehabilitation & Wellness Care
03/06/2026 -
NYC Physician Dr. Felix Cohen Expands Access to Advanced Treatment for Women Suffering from Abnormal Uterine Bleeding and Dysmenorrhea
03/06/2026 -
WORK Medical Technology Group Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy
03/06/2026 -
VALNEVA:Declaration of shares and voting rights - Status as of May 31, 2026
03/06/2026 -
MAIA Biotechnology Receives FDA Clearance to Open U.S. Enrollment in Ongoing Phase 2 THIO-101 Trial Expansion
03/06/2026 -
Physicians Warned against Indemnification Clauses in Contracts, according to the Journal of American Physicians and Surgeons
03/06/2026 -
LiveWorld Launches LiveInsight AI™, Creating a New Category of Intelligence Systems for Pharma
03/06/2026 -
Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 and Novel 12-LOX Platform at BIO International Convention 2026 Partnering Event
03/06/2026 -
OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
03/06/2026 -
JenaValve Appoints Maria Jose Arana as Vice President of Quality and Compliance
03/06/2026 -
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
03/06/2026 -
LiveWorld Marks 30th Anniversary with Business Model Transformation & Launch of LiveInsight AI™ Intelligence System
03/06/2026 -
Vital Nutrients Debuts Vital Nutrients Kids, a Practitioner-Grade Supplement Line Developed by Parents
03/06/2026 -
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
03/06/2026 -
Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program
03/06/2026 -
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
03/06/2026 -
Alpha Tau and Tolmar Announce Strategic Collaboration to Bring Alpha DaRT® Therapy to U.S. Urological Cancer Patients
03/06/2026
Pages